Case Report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse

Divya Kamat1, Tarun Narang1, Madhvi Ahuja2

  • 1Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Multidrug-resistant leprosy strains are a major threat to eradication efforts in India. This case highlights the need for drug resistance testing even in smear-negative leprosy relapse cases.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Leprosy transmission persists in India, potentially driven by emerging drug resistance.
  • Multidrug-resistant Mycobacterium leprae (M. leprae) strains pose a significant challenge to leprosy eradication programs.
  • Standard diagnostic methods like slit skin smear (SSS) and histopathology can be inconclusive in certain leprosy relapse cases.

Observation:

  • A case of leprosy relapse with multidrug-resistant M. leprae was identified.
  • The patient presented with a negative SSS and inconclusive histopathology results.
  • This presentation is unusual as drug resistance studies are typically performed on smear-positive relapse cases.

Findings:

  • Multidrug resistance was confirmed in a leprosy relapse case despite negative SSS and inconclusive histopathology.
  • Resistance to ofloxacin (OFL), a key reserve drug, was noted, raising further concern.
  • The findings challenge the conventional approach to leprosy drug resistance testing.

Implications:

  • Drug resistance testing for M. leprae should be considered even in smear-negative leprosy relapse cases.
  • The emergence of resistance to reserve drugs like ofloxacin necessitates urgent attention.
  • This case underscores the importance of adapting diagnostic strategies to combat evolving drug resistance in leprosy.

Related Concept Videos